Year: 2025
Type: article
Abstract: Allergen immunotherapy (AIT) has shown efficacy in the short and the long term in the management of allergic respiratory diseases, and it's administered subcutaneously (subcutaneous immunotherapy, or SCIT) or sublingually (sublingual immunotherapy, or SLIT), being both effective and safe options.
Source: Allergologia et Immunopathologia
Institution: Hospital de Sagunto
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,000
Funder: Allergy Therapeutics
OpenAlex ID: W4408080790
